This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Ken Lee
Director, Bioprocess Technologies and Engineering, BioPharmaceuticals Development, R&D at AstraZeneca


Ken received his PhD from the University of Birmingham, UK, in Chemical Engineering in 2009, after which he took up a position at TAP Biosystems, now Sartorius, as a development engineer on the ambr15 fed-batch workstation. He then joined AstraZeneca in 2011 and has been working as part of the cell culture bioreactor development team in Cambridge, UK then in Gaithersburg, US primarily on early phase projects. In 2020 Ken took an internal move to lead the Upstream Continuous Processing Platform team. As part of this role Ken was able to bring recirculating loop perfusion to AstraZeneca and demonstrate a robust and scalable process from ambr250 to 50L

Agenda Sessions

  • Chairperson's Opening Remarks

  • Panel Discussion: How many cell lines should you have?